203
Views
35
CrossRef citations to date
0
Altmetric
Drug Profile

Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia

, , , , &
Pages 381-391 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hanna Grauers Wiktorin, Ebru Aydin, Karin Christenson, Nuttida Issdisai, Fredrik B. Thorén, Kristoffer Hellstrand & Anna Martner. (2021) Impact of IL-1β and the IL-1R antagonist on relapse risk and survival in AML patients undergoing immunotherapy for remission maintenance. OncoImmunology 10:1.
Read now

Articles from other publishers (34)

Ana Sahores, Angela Rodríguez González, Agustín Yaneff, María May, Natalia Gómez, Federico Monczor, Natalia Fernández, Carlos Davio & Carina Shayo. (2023) Ceefourin-1, a MRP4/ABCC4 inhibitor, induces apoptosis in AML cells enhanced by histamine. Biochimica et Biophysica Acta (BBA) - General Subjects 1867:4, pages 130322.
Crossref
Ameya Fulmali & Sonali S. Bharate. (2022) Phosphate moiety in FDA‐approved pharmaceutical salts and prodrugs. Drug Development Research 83:5, pages 1059-1074.
Crossref
Mariángeles Clauzure, Mónica A. Táquez Delgado, Jude M. Phillip, Maria V. Revuelta, Leandro Cerchietti & Vanina A. Medina. (2022) Histamine H4 Receptor Agonism Induces Antitumor Effects in Human T-Cell Lymphoma. International Journal of Molecular Sciences 23:3, pages 1378.
Crossref
Steffen Pockes & Katharina Tropmann. (2021) Histamine H 2 receptor radioligands: triumphs and challenges . Future Medicinal Chemistry 13:12, pages 1073-1081.
Crossref
Erin C. Kaser, Lei Zhao, Kyle P. D’mello, Ziwen Zhu, Huaping Xiao, Mark R. Wakefield, Qian Bai & Yujiang Fang. (2021) The role of various interleukins in acute myeloid leukemia. Medical Oncology 38:5.
Crossref
Angela Rodríguez González, Ana Sahores, Antonela Díaz‐Nebreda, Agustín Yaneff, Nicolás Di Siervi, Natalia Gómez, Federico Monczor, Natalia Fernández, Carlos Davio & Carina Shayo. (2020) MRP4/ABCC4 expression is regulated by histamine in acute myeloid leukemia cells, determining cAMP efflux. The FEBS Journal 288:1, pages 229-243.
Crossref
Natalia C. Fernández & Federico Monczor. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 805 810 .
Natalia C. Fernández & Federico Monczor. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1 6 .
Noelia A Massari, Melisa B Nicoud & Vanina A Medina. (2018) Histamine receptors and cancer pharmacology: an update. British Journal of Pharmacology 177:3, pages 516-538.
Crossref
Melisa B. Nicoud, Karina Formoso & Vanina A. Medina. (2019) Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications. Frontiers in Pharmacology 10.
Crossref
Suman Mitra & Warren J Leonard. (2018) Biology of IL-2 and its therapeutic modulation: Mechanisms and strategies. Journal of Leukocyte Biology 103:4, pages 643-655.
Crossref
Natalia C. Fernández, Carina Shayo, Carlos Davio & Federico Monczor. 2017. Histamine Receptors as Drug Targets. Histamine Receptors as Drug Targets 67 114 .
Federico Monczor & Natalia Fernandez. (2016) Current Knowledge and Perspectives on Histamine H 1 and H 2 Receptor Pharmacology: Functional Selectivity, Receptor Crosstalk, and Repositioning of Classic Histaminergic Ligands . Molecular Pharmacology 90:5, pages 640-648.
Crossref
Rebecca Austin, Mark J. Smyth & Steven W. Lane. (2016) Harnessing the immune system in acute myeloid leukaemia. Critical Reviews in Oncology/Hematology 103, pages 62-77.
Crossref
Federico Monczor, Sabrina Copsel, Natalia Fernandez, Carlos Davio & Carina Shayo. 2017. Histamine and Histamine Receptors in Health and Disease. Histamine and Histamine Receptors in Health and Disease 141 160 .
Jiapeng Li, Xiaojun Huang, Qian Wang, Shan Jing, Hao Jiang, Zhongna Wei, Yannan Zang, Yang Liu, Libo Zhao, Yi Fang & Wanyu Feng. (2015) Pharmacokinetic Properties and Safety Profile of Histamine Dihydrochloride Injection in Chinese Healthy Volunteers: A Phase I, Single-center, Open-label, Randomized Study. Clinical Therapeutics 37:10, pages 2352-2364.
Crossref
Kristin Werner, Solveig Kälble, Sabine Wolter, Erich H. Schneider, Armin Buschauer, Detlef Neumann & Roland Seifert. (2015) Flow cytometric analysis with a fluorescently labeled formyl peptide receptor ligand as a new method to study the pharmacological profile of the histamine H2 receptor. Naunyn-Schmiedeberg's Archives of Pharmacology 388:10, pages 1039-1052.
Crossref
Zhi-Wei Ye, Jie Zhang, Danyelle M. Townsend & Kenneth D. Tew. (2015) Oxidative stress, redox regulation and diseases of cellular differentiation. Biochimica et Biophysica Acta (BBA) - General Subjects 1850:8, pages 1607-1621.
Crossref
Nicole Kagermeier, Kristin Werner, Max Keller, Paul Baumeister, Günther Bernhardt, Roland Seifert & Armin Buschauer. (2015) Dimeric carbamoylguanidine-type histamine H2 receptor ligands: A new class of potent and selective agonists. Bioorganic & Medicinal Chemistry 23:14, pages 3957-3969.
Crossref
Kristin Werner, Detlef Neumann & Roland Seifert. (2014) Analysis of the histamine H2-receptor in human monocytes. Biochemical Pharmacology 92:2, pages 369-379.
Crossref
Yi Wang, Yang Jiang, Jun‐ichiro Ikeda, Tian Tian, Atsushi Sato, Hiroshi Ohtsu & Eiichi Morii. (2014) Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line. Cancer Medicine 3:5, pages 1126-1135.
Crossref
Yangqiu Li. (2014) T-cell immune suppression in patients with hematologic malignancies: clinical implications. International Journal of Hematologic Oncology 3:4, pages 289-297.
Crossref
Y. Mao, I. Poschke & R. Kiessling. (2014) Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells. Journal of Internal Medicine 276:2, pages 154-170.
Crossref
Peter H. Wiernik. (2014) Optimal Therapy for Adult Patients with Acute Myeloid Leukemia in First Complete Remission. Current Treatment Options in Oncology 15:2, pages 171-186.
Crossref
Ali A. Akhiani, Olle Werlenius, Johan Aurelius, Charlotta Movitz, Anna Martner, Kristoffer Hellstrand & Fredrik B. Thorén. (2014) Role of the ERK Pathway for Oxidant-Induced Parthanatos in Human Lymphocytes. PLoS ONE 9:2, pages e89646.
Crossref
Anna Martner, Fredrik Bergh Thorén, Johan Aurelius & Kristoffer Hellstrand. (2013) Immunotherapeutic strategies for relapse control in acute myeloid leukemia. Blood Reviews 27:5, pages 209-216.
Crossref
Fuling Zhou, Qiang Shen & François X Claret. (2013) Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia. Journal of Leukocyte Biology 94:3, pages 423-429.
Crossref
Till M. Reher, Irena Brunskole, Detlef Neumann & Roland Seifert. (2012) Evidence for ligand-specific conformations of the histamine H2-receptor in human eosinophils and neutrophils. Biochemical Pharmacology 84:9, pages 1174-1185.
Crossref
Johan AureliusFredrik B. ThorénAli A. AkhianiMats Brune, Lars Palmqvist, Markus Hansson, Kristoffer HellstrandAnna Martner. (2012) Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91phox expression and the PARP-1/PAR pathway of apoptosis. Blood 119:24, pages 5832-5837.
Crossref
Régis T. Costello, Benjamin Knoblauch, Carole Sanchez, Delphine Mercier, Thérèse Le Treut & Gérard Sébahoun. (2012) Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia. Immunology 135:2, pages 151-157.
Crossref
Xiang Dong Yang & Timothy C Wang. (2011) Reply to Antitumor properties of histamine in vivo. Nature Medicine 17:5, pages 537-538.
Crossref
Fredrik B Thoren, Johan Aurelius & Anna Martner. (2011) Antitumor properties of histamine in vivo. Nature Medicine 17:5, pages 537-537.
Crossref
Lily P.H. Yang & Caroline M. Perry. (2011) Spotlight on Histamine Dihydrochloride in Acute Myeloid Leukaemia†. Drugs & Aging 28:4, pages 325-329.
Crossref
Lily P.H. Yang & Caroline M. Perry. (2011) Histamine Dihydrochloride. Drugs 71:1, pages 109-122.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.